Published

1933-07-01

Noticias clinicas: El Solusalvarsan (Bayer) en Sifiliterapia

Keywords:

notas clinicas, solusalvarsan, (bayer), sifiliterapia, ulceración vulvar, sífilis (es)

Downloads

Authors

  • Angel María Romero G. Universidad Nacional de Colombia
N. N., de 20 años de edad, natural de Bogotá; profesión, costurera. No tiene antecedentes heredosifilítioos, y su peso actual Son 50 kilos. Vista por la primera vez el 21 de abril de 1933, me refiere que hace unas nueve semanas tuvo un contacto venéreo y a las tres semanas le apareció una ulceración vulvar, poco dolorosa y que persistió durante un mes; a los quince días después de cicatrizada o sea a las seis semanas de la aparición del accidente primario, estallaron los accidentes que motivaron mi visita y que consistían en.

How to Cite

APA

Romero G., A. M. (1933). Noticias clinicas: El Solusalvarsan (Bayer) en Sifiliterapia. Revista de la Facultad de Medicina, 2(2), 154–157. https://revistas.unal.edu.co/index.php/revfacmed/article/view/22546

ACM

[1]
Romero G., A.M. 1933. Noticias clinicas: El Solusalvarsan (Bayer) en Sifiliterapia. Revista de la Facultad de Medicina. 2, 2 (Jul. 1933), 154–157.

ACS

(1)
Romero G., A. M. Noticias clinicas: El Solusalvarsan (Bayer) en Sifiliterapia. Rev. Fac. Med. 1933, 2, 154-157.

ABNT

ROMERO G., A. M. Noticias clinicas: El Solusalvarsan (Bayer) en Sifiliterapia. Revista de la Facultad de Medicina, [S. l.], v. 2, n. 2, p. 154–157, 1933. Disponível em: https://revistas.unal.edu.co/index.php/revfacmed/article/view/22546. Acesso em: 4 aug. 2024.

Chicago

Romero G., Angel María. 1933. “Noticias clinicas: El Solusalvarsan (Bayer) en Sifiliterapia”. Revista De La Facultad De Medicina 2 (2):154-57. https://revistas.unal.edu.co/index.php/revfacmed/article/view/22546.

Harvard

Romero G., A. M. (1933) “Noticias clinicas: El Solusalvarsan (Bayer) en Sifiliterapia”, Revista de la Facultad de Medicina, 2(2), pp. 154–157. Available at: https://revistas.unal.edu.co/index.php/revfacmed/article/view/22546 (Accessed: 4 August 2024).

IEEE

[1]
A. M. Romero G., “Noticias clinicas: El Solusalvarsan (Bayer) en Sifiliterapia”, Rev. Fac. Med., vol. 2, no. 2, pp. 154–157, Jul. 1933.

MLA

Romero G., A. M. “Noticias clinicas: El Solusalvarsan (Bayer) en Sifiliterapia”. Revista de la Facultad de Medicina, vol. 2, no. 2, July 1933, pp. 154-7, https://revistas.unal.edu.co/index.php/revfacmed/article/view/22546.

Turabian

Romero G., Angel María. “Noticias clinicas: El Solusalvarsan (Bayer) en Sifiliterapia”. Revista de la Facultad de Medicina 2, no. 2 (July 1, 1933): 154–157. Accessed August 4, 2024. https://revistas.unal.edu.co/index.php/revfacmed/article/view/22546.

Vancouver

1.
Romero G. AM. Noticias clinicas: El Solusalvarsan (Bayer) en Sifiliterapia. Rev. Fac. Med. [Internet]. 1933 Jul. 1 [cited 2024 Aug. 4];2(2):154-7. Available from: https://revistas.unal.edu.co/index.php/revfacmed/article/view/22546

Download Citation

Article abstract page views

238

Downloads

Download data is not yet available.

License

Copyright

Authors must agree to transfer to the Revista de la Facultad de Medicina the copyright of the articles published in the Journal. The publisher has the right to use, reproduce, transmit, distribute and publish the articles in any form. Authors will not be able to permit or authorize the use of their published paper without the written consent of the Journal.

The letter of copyright transfer and the letter of authorship responsibility must be submitted along with the original paper through the Journal OJS platform. These files are available in https://goo.gl/EfWPdX y https://goo.gl/6zztk4 and must be uploaded in step 4 (supplementary files).

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).